Social Determinants of Health and 1-Year Buprenorphine Initiation Among Justice-Involved Veterans

Jama Network Open

by Sharmin Sultana, Feiyun Ouyang, Junhui Qian, Yifan Zhang, Avijit Mitra, Richeek Pradhan, Yousef Moradi, Terri K. Pogoda, Joel I. Reisman, Hong Yu
April 17, 2026

Jama Network Open

Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial

by Christian S. Hendershot, Michael P. Bremmer, Michael B. Paladino, Georgios Kostantinis, Thomas A. Gilmore, Neil R. Sullivan, Amanda C. Tow, Mark A. Prince, Sarah S. Dermody, Robyn Jordan, Sherry A. McKee, Paul J. Fletcher, Eric D. Claus, Klara R. Klein
May 26, 2026

Conexiant

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

by Kathryn Wighton
May 27, 2026
5 min

Frontiers In Psychiatry

Toward clarifying ASAM’s inpatient and residential benzodiazepine tapering recommendations

by Christopher K. Blazes, Stephen Leung, Doryn Davis Chervin, Bernard Silvernail
May 26, 2026

Social Determinants of Health and 1-Year Buprenorphine Initiation Among Justice-Involved Veterans

Original Source(s)

Social Determinants of Health and 1-Year Buprenorphine Initiation Among Justice-Involved Veterans

Related Content

Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial

GLP-1 Drugs Tied to Lower Addiction Risk

Toward clarifying ASAM’s inpatient and residential benzodiazepine tapering recommendations